Augmentation of lymphocyte responses by monoclonal antibodies to the gangliosides GD3 and GD2: The role of protein kinase C, cyclic nucleotides, and intracellular calcium
- 31 March 1989
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 119 (2) , 263-278
- https://doi.org/10.1016/0008-8749(89)90243-8
Abstract
No abstract availableThis publication has 63 references indexed in Scilit:
- Expression of the gangliosides GD3 and GD2 on lymphocytes in tissue sections of melanomaPathology, 1988
- Expression of the gangliosides GM3, GD3 and GD2 in tissue sections of normal skin, naevi, primary and metastatic melanomaInternational Journal of Cancer, 1988
- An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cation-dependent functional complex with the disialoganglioside GD2.The Journal of cell biology, 1987
- Interleukin II increases cyclic GMP levels in immature thymocytes and mitogen-primed T-lymphocytesInternational Journal of Immunopharmacology, 1987
- Protein kinase C in T-cell regulationImmunology Today, 1986
- Studies and Perspectives of Protein Kinase CScience, 1986
- Interleukin-2 stimulates association of protein kinase C with plasma membraneNature, 1985
- Tumor promoter phorbol esters induce unresponsiveness to antigen and expression of interleukin 2 receptor on T cellsEuropean Journal of Immunology, 1985
- Transient expression of interleukin 2 receptors. Consequences for T cell growth.The Journal of Experimental Medicine, 1983
- Cyclic Nucleotides as Intracellular Mediators of the Expression of Antigen-sensitive CellsNature, 1973